So How does Biel get to $.01 Share Price In Th
Post# of 7807
(Total Views: 180)
Posted On: 02/26/2019 12:10:03 PM
So How does Biel get to $.01 Share Price
In The Short Run
Simple 83,500 Actipatches Sold a Quarter and a 100 PE will do it.
Currently Biel Sells about 15,000 a Quarter.
Upward Explosion in Price at Any Time.
(I think the PE will be much Higher) Why? Hyper Growth Mode at This Point.
CLUE: It will be there SOON!!
Biel Share Price Per Each 1 Million Actipatches Sold Per Year.
Estimated Profit Per Actipatch after all Costs is $7.00
Think Profit is half that, divide the following numbers by two or any other number.
21 Billion shares outstanding and 25 Billion Authorized. I will use a 25 Billion figure.
$7,000,000 divided by 25 Billion = $.00028 X PE =
PE 30 = $.0084
PE 60 = $.0168
PE 120 =$.0336
High growth companies can sport a much higher PE.
Those numbers are for just $7,000,000 profit in a Year or $1,750,000 Profit Per Quarter.
That is for 1,000,000 Actipatches Sold Per Year.
Keep in mind the Average User Uses 2.7 Actipatches a Year,
and that Number is Expected to be 10.8 Actipatches Per User a Year in the U.K.,
with the Government of the U.K. paying for the Actipatches.
Rest of the World is Predicted to use 2.7 Per User Per Year, so only about 370,000
Users Worldwide are needed for a Million Actipatch Sales.
So do you think Biel will sell 10 Million Actipatches a Year? ABSOLUTELY YES.
Multiply those PE numbers by 10. --- Yes, that is $.084 to $.336 per share.
50 Million Actipatches a year?
Multiply those PE numbers by 50. --- Yes, that is $.42 to $1.68
100 Million Actipatches a Year?
Multiply those PE numbers by 100. --- Yes that is $.84 to $3.36
Adjust the numbers as you wish, this is a price predicting model based on sales.
There is NOTHING wrong with the share structure other than widely held false beliefs.
Currently Biel is equivalent to 10 Million Shares Outstanding at $1.68
CLUE: NHS average user is predicted to use 10.8 Actipatches a year.
Just 100,000 users is 1,080,000 Actipatches purchased per year.
NHS is the Government of the U.K. which is PAYING for Actipatches for their
Estimated 25-29 Million pain sufferers.
In The Short Run
Simple 83,500 Actipatches Sold a Quarter and a 100 PE will do it.
Currently Biel Sells about 15,000 a Quarter.
Upward Explosion in Price at Any Time.
(I think the PE will be much Higher) Why? Hyper Growth Mode at This Point.
CLUE: It will be there SOON!!
Biel Share Price Per Each 1 Million Actipatches Sold Per Year.
Estimated Profit Per Actipatch after all Costs is $7.00
Think Profit is half that, divide the following numbers by two or any other number.
21 Billion shares outstanding and 25 Billion Authorized. I will use a 25 Billion figure.
$7,000,000 divided by 25 Billion = $.00028 X PE =
PE 30 = $.0084
PE 60 = $.0168
PE 120 =$.0336
High growth companies can sport a much higher PE.
Those numbers are for just $7,000,000 profit in a Year or $1,750,000 Profit Per Quarter.
That is for 1,000,000 Actipatches Sold Per Year.
Keep in mind the Average User Uses 2.7 Actipatches a Year,
and that Number is Expected to be 10.8 Actipatches Per User a Year in the U.K.,
with the Government of the U.K. paying for the Actipatches.
Rest of the World is Predicted to use 2.7 Per User Per Year, so only about 370,000
Users Worldwide are needed for a Million Actipatch Sales.
So do you think Biel will sell 10 Million Actipatches a Year? ABSOLUTELY YES.
Multiply those PE numbers by 10. --- Yes, that is $.084 to $.336 per share.
50 Million Actipatches a year?
Multiply those PE numbers by 50. --- Yes, that is $.42 to $1.68
100 Million Actipatches a Year?
Multiply those PE numbers by 100. --- Yes that is $.84 to $3.36
Adjust the numbers as you wish, this is a price predicting model based on sales.
There is NOTHING wrong with the share structure other than widely held false beliefs.
Currently Biel is equivalent to 10 Million Shares Outstanding at $1.68
CLUE: NHS average user is predicted to use 10.8 Actipatches a year.
Just 100,000 users is 1,080,000 Actipatches purchased per year.
NHS is the Government of the U.K. which is PAYING for Actipatches for their
Estimated 25-29 Million pain sufferers.
(1)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼